Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification.
Shinozuka T, Tsukada T, Fujii K, Tokumaru E, Shimada K, Onishi Y, Matsui Y, Wakimoto S, Kuroha M, Ogata T, Araki K, Ohsumi J, Sawamura R, Watanabe N, Yamamoto H, Fujimoto K, Tani Y, Mori M, Tanaka J. Shinozuka T, et al. Among authors: fujii k. Bioorg Med Chem. 2018 Oct 1;26(18):5079-5098. doi: 10.1016/j.bmc.2018.09.006. Epub 2018 Sep 8. Bioorg Med Chem. 2018. PMID: 30241907
Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization.
Shinozuka T, Tsukada T, Fujii K, Tokumaru E, Shimada K, Onishi Y, Matsui Y, Wakimoto S, Kuroha M, Ogata T, Araki K, Ohsumi J, Sawamura R, Watanabe N, Yamamoto H, Fujimoto K, Tani Y, Mori M, Tanaka J. Shinozuka T, et al. Among authors: fujii k. Bioorg Med Chem. 2018 Oct 1;26(18):5099-5117. doi: 10.1016/j.bmc.2018.09.005. Epub 2018 Sep 8. Bioorg Med Chem. 2018. PMID: 30220602
Structure-Activity Relationship Studies of 3- or 4-Pyridine Derivatives of DS-6930.
Shinozuka T, Tsukada T, Fujii K, Tokumaru E, Matsui Y, Wakimoto S, Ogata T, Araki K, Sawamura R, Watanabe N, Mori M, Tanaka J. Shinozuka T, et al. Among authors: fujii k. ACS Med Chem Lett. 2019 Feb 26;10(3):358-362. doi: 10.1021/acsmedchemlett.8b00645. eCollection 2019 Mar 14. ACS Med Chem Lett. 2019. PMID: 30891140 Free PMC article.
Novel FtsZ inhibitor with potent activity against Staphylococcus aureus.
Kumar M, Mathur T, Barman TK, Chaira T, Kumar R, Joshi V, Pandya M, Sharma L, Fujii K, Bandgar M, Jadhav B, Bambal R, Upadhyay D, Masuda N, Verma AK, Bhatnagar PK. Kumar M, et al. Among authors: fujii k. J Antimicrob Chemother. 2021 Oct 11;76(11):2867-2874. doi: 10.1093/jac/dkab270. J Antimicrob Chemother. 2021. PMID: 34383913
Identification of factors related to functional prognoses in craniopharyngiomas.
Umeda T, Otani Y, Fujii K, Ishida J, Hirano S, Suruga Y, Kemmotsu N, Imoto R, Kegoya Y, Mizuta R, Inoue Y, Hokama M, Makihara S, Hasegawa K, Inagaki K, Otsuka F, Yasuhara T, Tanaka S. Umeda T, et al. Among authors: fujii k. J Neurooncol. 2025 Jan 22. doi: 10.1007/s11060-024-04925-7. Online ahead of print. J Neurooncol. 2025. PMID: 39841323
Impact of time to treatment initiation on the development of cachexia and clinical outcomes in lung cancer.
Katsushima U, Kurose S, Fukushima T, Nakano J, Ogushi N, Fujii K, Nagata Y, Kamisako K, Okuno Y, Okazaki Y, Nakanishi K, Yoshida K, Ikoma T, Takeyasu Y, Yamanaka Y, Yoshioka H, Hase K, Kurata T. Katsushima U, et al. Among authors: fujii k. Jpn J Clin Oncol. 2025 Jan 18:hyaf009. doi: 10.1093/jjco/hyaf009. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39825794
3,906 results